OSIRIS THERAPEUTICS, INC. 4
4 · OSIRIS THERAPEUTICS, INC. · Filed Aug 16, 2013
Insider Transaction Report
Form 4
FRIEDLI PETER
Director10% OwnerOther
Transactions
- Exercise/Conversion
Common Stock Purchase Warrant
2013-08-14−1,000,000→ 0 totalExercise: $11.00From: 2006-05-24Exp: 2015-05-24→ Common Stock (1,000,000 underlying) - Exercise/Conversion
Common Stock
2013-08-14$11.00/sh+1,000,000$11,000,000→ 10,626,794 total - Tax Payment
Common Stock
2013-08-14$25.44/sh−432,390$11,000,002→ 10,194,404 total
Holdings
- 4,606,051(indirect: Note 2)
Common Stock
Footnotes (2)
- [F1]The Reporting Person converted a Warrant using the Net Exercise Right provided for in the Warrant into shares of the Registrant's common stock. The fair market value of the common stock at the time of the conversion was $25.44 per share and a total of 432,390 shares of common stock were surrendered to facilitate the issuance of 567,610 shares of common stock.
- [F2]The Reporting Person holds indirect beneficial ownership of 4,103,301 shares of common stock held by Venturetec, Inc., 500,000 shares held by his minor daughter and 2,750 shares held by his spouse. The Reporting Person holds approximately a 3% interest in Venturetec, Inc. and serves as its president. The Reporting Person disclaims beneficial ownership in the shares held by his daughter and spouse and disclaims beneficial interest in the shares held by Venturetec, Inc., beyond the extent of his pecuniary interest therein.